Daniela De Zio
Odense, 5230, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A Phase 1b/2 Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden.
Journal: Cancer research communications
Published: April 08, 2026
Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 24, 2025
Characterization of human melanoma skin cancer models: A step towards model-based melanoma research.
Characterization of human melanoma skin cancer models: A step towards model-based melanoma research.
Journal: Acta biomaterialia
Published: August 29, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 13, 2024
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.
Journal: Cancer immunology, immunotherapy : CII
Published: November 07, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2023
AMBRA1 phosphorylation by CDK1 and PLK1 regulates mitotic spindle orientation.
Journal: Cellular and molecular life sciences : CMLS
Published: December 31, 2022
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Journal: Oncoimmunology
Published: December 22, 2022
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.
Journal: Cell death & disease
Published: October 03, 2022
GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.
Journal: Cell reports
Published: August 08, 2022
Last Updated: 09/26/2026